Thomas P.H. Meyer

518 total citations
7 papers, 323 citations indexed

About

Thomas P.H. Meyer is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Thomas P.H. Meyer has authored 7 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Virology and 3 papers in Immunology. Recurrent topics in Thomas P.H. Meyer's work include Poxvirus research and outbreaks (5 papers), Bacillus and Francisella bacterial research (4 papers) and Immunotherapy and Immune Responses (3 papers). Thomas P.H. Meyer is often cited by papers focused on Poxvirus research and outbreaks (5 papers), Bacillus and Francisella bacterial research (4 papers) and Immunotherapy and Immune Responses (3 papers). Thomas P.H. Meyer collaborates with scholars based in United States, Germany and South Korea. Thomas P.H. Meyer's co-authors include Darja Schmidt, Paul Chaplin, Heinz Weidenthaler, Günter Silbernagl, Joachim Hornung, Phillip R. Pittman, Christopher R. Heery, Jane Maclennan, Matthew W. Hahn and Richard Nichols and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Thomas P.H. Meyer

7 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P.H. Meyer United States 5 218 186 172 81 47 7 323
Günter Silbernagl Germany 7 203 0.9× 169 0.9× 196 1.1× 76 0.9× 43 0.9× 8 310
Marie-Lise Blondot France 8 85 0.4× 94 0.5× 245 1.4× 139 1.7× 43 0.9× 14 361
David Alejandro Bejarano Germany 6 136 0.6× 121 0.7× 38 0.2× 98 1.2× 46 1.0× 10 276
Gilberto Betancor United Kingdom 11 213 1.0× 116 0.6× 60 0.3× 154 1.9× 95 2.0× 16 316
Bryan Tegomoh United States 2 168 0.8× 152 0.8× 130 0.8× 110 1.4× 7 0.1× 5 293
Audrey Brussel France 9 395 1.8× 126 0.7× 104 0.6× 229 2.8× 149 3.2× 9 471
Shringar Rao Netherlands 11 116 0.5× 241 1.3× 42 0.2× 91 1.1× 78 1.7× 20 385
Bhavna Hora United States 10 155 0.7× 54 0.3× 86 0.5× 113 1.4× 63 1.3× 27 259
Jane Maclennan United States 4 219 1.0× 181 1.0× 153 0.9× 52 0.6× 46 1.0× 5 274
Sandra Scherbeijn Netherlands 6 156 0.7× 122 0.7× 234 1.4× 68 0.8× 41 0.9× 11 371

Countries citing papers authored by Thomas P.H. Meyer

Since Specialization
Citations

This map shows the geographic impact of Thomas P.H. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P.H. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P.H. Meyer more than expected).

Fields of papers citing papers by Thomas P.H. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P.H. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P.H. Meyer. The network helps show where Thomas P.H. Meyer may publish in the future.

Co-authorship network of co-authors of Thomas P.H. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P.H. Meyer. A scholar is included among the top collaborators of Thomas P.H. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P.H. Meyer. Thomas P.H. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Greenberg, Richard N., Darja Schmidt, Jane Maclennan, et al.. (2024). Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine. Human Vaccines & Immunotherapeutics. 20(1). 2384189–2384189. 2 indexed citations
2.
Schmidt, Darja, Thomas P.H. Meyer, Günter Silbernagl, et al.. (2022). One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines. The Journal of Infectious Diseases. 227(10). 1203–1213. 26 indexed citations
3.
Volkmann, Ariane, Anna‐Lise Williamson, Heinz Weidenthaler, et al.. (2020). The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. Vaccine. 39(22). 3067–3080. 36 indexed citations
4.
Schmidt, Darja, et al.. (2020). Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial. Vaccine. 38(11). 2608–2619. 48 indexed citations
5.
Pittman, Phillip R., Matthew W. Hahn, Darja Schmidt, et al.. (2019). Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox. New England Journal of Medicine. 381(20). 1897–1908. 156 indexed citations
6.
Greenberg, Richard N., Christine M. Hay, Jack T. Stapleton, et al.. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PLoS ONE. 11(6). e0157335–e0157335. 54 indexed citations
7.
Meyer, Edwin F. & Thomas P.H. Meyer. (1986). Supercritical fluid: Liquid, gas, both, or neither? A different approach. Journal of Chemical Education. 63(6). 463–463. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026